reference/24094415

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24094415

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, U.S. Gov't, P.H.S.
endingPage	1750
issn	0027-8874 1460-2105
issueIdentifier	23
pageRange	1743-1750
publicationName	JNCI Journal of the National Cancer Institute
startingPage	1743
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9d9f3bfe980df402e21f555a94799d0a
bibliographicCitation	Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL, Omenn GS, Valanis B, Williams JH. The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping -Carotene and Retinol Supplements. JNCI Journal of the National Cancer Institute. 2004 Nov 30;96(23):1743–50. doi: 10.1093/jnci/djh320.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7579f4661cf1e32adef961d8d1f860c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f342e7f34786c870eed253c4c7b5344a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dbac970f16039a9f21e168d4f62f027 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b24fb51250ce6abfa5de9ea2ada038f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_848fa5db044b7708d589b539407844af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31df7601a432350470a9bd77b31237e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27b51ff1630d5b3385cdb685bfb1eaa9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f0bed730533ff3ceefd9bb88a38620d
date	2004-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1093/jnci/djh320 https://pubmed.ncbi.nlm.nih.gov/15572756
isPartOf	https://portal.issn.org/resource/ISSN/1460-2105 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4982 https://portal.issn.org/resource/ISSN/0027-8874
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements
discusses	http://id.nlm.nih.gov/mesh/M0028611 http://id.nlm.nih.gov/mesh/M0003416 http://id.nlm.nih.gov/mesh/M0025302
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000139 http://id.nlm.nih.gov/mesh/D019207Q000008 http://id.nlm.nih.gov/mesh/D008175Q000453 http://id.nlm.nih.gov/mesh/D002318Q000401 http://id.nlm.nih.gov/mesh/D016588Q000008 http://id.nlm.nih.gov/mesh/D019207Q000009 http://id.nlm.nih.gov/mesh/D002273Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D016588Q000009 http://id.nlm.nih.gov/mesh/D014481Q000453 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D008175Q000517 http://id.nlm.nih.gov/mesh/D002273Q000008 http://id.nlm.nih.gov/mesh/D012737 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016001 http://id.nlm.nih.gov/mesh/D015994
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280531 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280489 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129252034 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128797476 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127880219

Total number of triples: 65.